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Summary
Posttranscriptional regulatory mechanisms control
TNF expression through AU-rich elements in the
3UTR of its mRNA. This is mediated through Erk and
p38 MAP kinase signaling, although the mechanisms
involved remain poorly understood. Here, we show
that the MAP kinase signal-integrating kinases (Mnks),
which are activated by both these pathways, regulate
TNF expression in T cells via the 3UTR. A selective
Mnk inhibitor or siRNA-mediated knockdown of Mnk1
inhibits TNF production in T cells, whereas Mnk1
overexpression enhances expression of a reporter
construct containing the TNF 3UTR. We identify
ARE binding proteins that are Mnk substrates, such
as hnRNP A1, which they phosphorylate at two sites
in vitro. hnRNP A1 is phosphorylated in response to T
cell activation, and this is blocked by Mnk inhibition.
Moreover, Mnk-mediated phosphorylation decreases
binding of hnRNP A1 to TNF-ARE in vitro or TNF-
mRNA in vivo. Therefore, Mnks are novel players in
cytokine regulation and potential new targets for anti-
inflammatory therapy.
Introduction
Tumor necrosis factor (TNF) α plays a crucial role in
controlling inflammatory phenomena, and its expres-
sion is therefore tightly regulated. TNFα is primarily pro-
duced by activated macrophages, but it is also synthe-
sized by T lymphocytes. Its overproduction by these
cells is linked to pathological situations such as super-
antigen-induced septic shock (Miethke et al., 1992),*Correspondence: cgpr@interchange.ubc.ca
6 Present Address: Department of Biochemistry and Molecular Biol-
ogy, University of British Columbia, 2350 Health Sciences Mall,
Vancouver, British Columbia, V6T 1Z3, Canada.rheumatoid arthritis, and inflammatory bowel disease
(Feldmann et al., 1996).
The synthesis of TNFα is under complex control, and
regulation occurs at both the transcriptional and post-
transcriptional levels. The 3# untranslated region (UTR)
of the TNFα mRNA has been defined as playing the
major role in the posttranscriptional control of TNFα ex-
pression (Kruys et al., 1992). Its AU-rich elements (AREs)
can control the transport of the TNFα mRNA from the
nucleus to the cytoplasm (Dumitru et al., 2000), desta-
bilize the message (Kontoyiannis et al., 1999), and in-
hibit its translation (Han et al., 1990). Consistent with
this, transgenic mice expressing TNFα lacking the ARE
overexpress TNFα, leading to chronic inflammatory ar-
thritis and Crohn’s-like inflammatory bowel disease
(Kontoyiannis et al., 1999).
The regulation conferred by the AREs is mediated
through proteins that bind to them, the ARE binding
proteins (ARE-BPs), which are essential for the post-
transcriptional control of TNFα production (Lai et al.,
1999; Piecyk et al., 2000). Much work has been done
to characterize these ARE-BPs but, although several
proteins have been identified, little is known about how
the function of the RNA/protein complexes is modu-
lated. It is well established that the regulation of TNFα
production in macrophages and T cells involves both
the Erk and p38 MAP kinase pathways. Pyridinyl imid-
azoles such as SB203580, potent inhibitors of p38 MAP
kinase α/β (MAPK), were first discovered as anti-inflam-
matory drugs through their ability to impair TNFα pro-
duction. The compound PD098059, an inhibitor of MEK1,
also blocks TNFα synthesis (Dumont et al., 1998). In
peripheral T cells, TNFα production seems to be more
dependent on the Erk pathway than on p38 MAPK sig-
naling. Similarly, it has also been shown that TNFα pro-
duction by human T cells activated by anti-CD3 and
anti-CD28 monoclonal antibodies is inhibited by both
PD098059 and SB203580. This again suggests that the
Erk and p38 pathways both modulate TNFα expression
(Ballester et al., 1998; Buxadé et al., 2001; Hoffmeyer et
al., 1999). Thus, these enzymes, or downstream kinases
activated by them, are important in controlling, for ex-
ample, the stability and/or translation of the TNFα
mRNA in T cells.
To date, MAP kinase-activated protein kinase-2 (MK-2)
is the only kinase that has been shown to be involved
in regulating specific messages through direct phos-
phorylation of proteins bound to the 3#UTR. MK-2 is
activated by p38 MAPKα/β and is necessary for LPS-
induced TNFα biosynthesis in murine macrophages
(Kotlyarov et al., 1999). It has been reported that MK-2
phosphorylates three RNA-BPs that associate with
TNFα mRNA, tristetraprolin (TTP) (Chrestensen et al.,
2004), HuR (Tran et al., 2003) and heterogeneous nu-
clear (hn) ribonucleoprotein (RNP) A0 (Rousseau et al.,
2002). Since TTP and HuR affect the stability of the
TNFα mRNA, they may explain how the p38 MAPK
pathway regulates TNFα mRNA stability. However, the
signaling connections between the p38 MAPK pathway
and the control of the translation of the TNFα mRNA
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lated by the Erk pathway, the mechanism(s) by which
Erk controls TNFα synthesis is unknown.
The MAP kinase signal-integrating kinases (Mnks) are
phosphorylated and activated by both the Erk1/2 and
the p38 MAP kinases α/β (Fukunaga and Hunter, 1997;
Waskiewicz et al., 1997, 1999). Mnk1 and Mnk2 are en-
coded by different genes and show different regulatory
properties: Mnk2 has high basal activity while Mnk1 is
stimulated markedly by signaling through Erk or p38
MAP kinase (Scheper et al., 2001, 2003). The only well-
characterized substrate for the Mnks is eukaryotic initi-
ation factor 4E (eIF4E), which binds the 5# cap structure
of eukaryotic cytoplasmic mRNAs (Gingras et al., 1999)
to facilitate cap-dependent translation. Phosphoryla-
tion of eIF4E at its physiological site, Ser209, reduces
its affinity for the cap structure and may stimulate cap-
dependent mRNA translation (Scheper et al., 2002).
Mnk1 needs to be bound to the scaffold protein eIF4G
to phosphorylate eIF4E (Pyronnet et al., 1999; Waskie-
wicz et al., 1999). eIF4G binds simultaneously to eIF4E
and the poly(A) binding protein, thereby promoting
mRNA circularization (Mazumder et al., 2003), thus po-
tentially bringing the Mnks close to proteins bound to
the 3#UTR.
Here, we provide several lines of evidence that the
Mnks play important roles in the posttranscriptional
regulation of TNFα synthesis in T cells by mechanisms
that involve its 3#UTR. Overexpression of Mnk1 en-
hances protein expression from a reporter containing
the TNFα 3#UTR, whereas inhibition or knockdown of
Mnks blocks synthesis of endogenous TNFα. We iden-
tify novel substrates for the Mnks that bind specifically
to the ARE of TNFα mRNA. One of these, hnRNP A1, is
a known ARE binding protein involved in the posttran-
scriptional regulation of gene expression in both the
nucleus and the cytoplasm. T cell activation results in
phosphorylation of hnRNP A1 at the Mnk sites, and de-
creases its ability to bind the TNFα mRNA in vivo, in a
Mnk-dependent manner. The Mnks thus appear to reg-
ulate the translation of specific messages such as
TNFα by phosphorylating proteins that bind its 3#UTR
and are therefore promising novel targets for specific
anti-inflammatory therapy. Furthermore, these data
show that the Mnks can phosphorylate proteins that
bind either end of mRNA and regulate specific mRNAs.
Results and Discussion
Regulation of TNF Synthesis in Jurkat Cells
Involves Signaling through the Erk
and p38 MAP Kinase Pathways
To address which signaling pathway(s) are involved in
regulating TNFα synthesis in T cells, we used PD98059
(a potent inhibitor of MEK1, the upstream activator of
Erk [Dudley et al., 1995]) and SB203580 (inhibits p38
MAP kinases α and β [Cuenda et al., 1995]). To verify
their efficacy, we examined the phosphorylation of Erk
and the activity of MK-2, a downstream effector of p38
MAP kinase α/β (Shi and Gaestel, 2002). PD98059 sub-
stantially blocked activation of Erk, as assessed by its
phosphorylation at the T-loop sites (Figure 1A). Anti-
CD3/anti-CD28 also activate the p38 MAP kinase path-
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tigure 1. Roles of Erk and p38 MAP Kinase Pathways in TNFα Pro-
uction in Jurkat Cells
urkat cells growing in DMEM plus 10% FCS were treated (where
hown) for 1 hr with 30 M PD98059, 10 M SB203580 or DMSO
vehicle), and then stimulated with anti-CD3 or anti-CD3/anti-CD28
efore harvesting.
A) 30 min later, the activation states of Erk1/2 were determined
y immunoblotting with phospho-Erk antibodies (upper panel). As
oading control, the same membrane was reprobed with anti-Erk2
lower panel).
B) Activation of p38 MAPK signaling was assayed by an in vitro
inase assay using hsp27 (a substrate for MK-2, which is activated
y p38 MAPKα/β), 30 min after stimulation. An autoradiograph of
he gel is shown.
C) TNFα secretion in cell supernatants was measured by ELISA 90
in after stimulation. The data represent the average ± SD of three
ndependent experiments.ay and this effect was inhibited by SB203580 (Figure
B). We consistently observed that SB203580 en-
anced Erk phosphorylation. This is consistent with
ther studies showing that activation of p38α enhances
ts binding to Erk1/2, blocking phosphorylation by
EK1 (Zhang et al., 2001). When used individually, each
ompound partially inhibited the marked increase in
NFα production caused by anti-CD3/anti-CD28 (Fig-
re 1C). Only in combination did they completely inhibit
NFα production, indicating that both pathways must
e blocked to fully inhibit induction. The finding that
B203580 has a smaller effect than PD98059 may
ither reflect a lesser role for this pathway in activating
NFα production in T cells or its ability to enhance
rk activity.
These data imply that expression of endogenous
NFα is regulated through signaling events that involve
oth Erk and p38 MAP kinase. Extensive work has been
arried out to define how p38 MAP kinase controls
NFα synthesis in macrophages (Salituro et al., 1999).
K-2 has been implicated in regulating the stability
nd/or translation of the TNFα mRNA (Neininger et al.,
002). While this enzyme may, at least in part, explain
he input from p38 MAP kinase, MK-2 is not activated
y Erk and cannot explain its input. As Mnk1 is acti-
ated by both these pathways, we asked whether con-
rol of TNFα production involved this enzyme.
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by the Mnk Inhibitor
To study the role of the Mnks in the production of endog-
enous TNFα, we used the Mnk inhibitor 4-amino-3-(p-fluo-
rophenylamino)pyrazolo[3,4-d]pyrimidine (Knauf et al.,
2001; CGP57380). T cell activation markedly increased
eIF4E phosphorylation, and this was prevented by
CGP57380 in a dose-dependent manner, being almost
completely blocked at 40 M (Figure 2A). Production of
TNFα, measured by ELISA in cell supernatants, was
also markedly inhibited by this compound in a dose-
dependent manner (Figure 2B), consistent with direct
involvement of the Mnks in regulating TNFα synthesis
in vivo. Importantly, CGP57380 had no effect on the
phosphorylation of Erk or hsp27, a specific substrate
for MK-2, which is activated by p38 MAP kinases α/β
(Figure 2C), indicating that CGP57380 does not in-
terfere with activation or activity of the Erk pathway,
p38 MAP kinases α/β or MK-2.
To explore further the specificity of CGP57380, we
assessed whether it inhibited a range of other relevant
protein kinases that are related to the Mnks (e.g., RSK1
or MSK1) involved in pathways that regulate the Mnks
(ERK2, p38 MAPKα, β, γ, and δ, and MKK1) or activated
by MAP kinases (PRAK, MK2). In vitro, CGP57380 did
not inhibit p38 MAP kinase β at all, and the IC50 for
MK2, p38 γ and δ, MSK1, and PRAK was about 70–
100 times higher than the IC50 against Mnk1 or Mnk2.
CGP57380 showed slight inhibitory action against
MKK1, ERK2, RSK1, and p38 MAPKα but only at con-
centrations 25–40 times higher than those that inhibit
Mnk1/2 (Table S1 in the Supplemental Data available
with this article online). Therefore, the effects of
CGP57380 on TNFα synthesis are not due to inhibition
of either of the upstream signaling pathways or of other
related protein kinases.
It was possible that inhibition of the Mnks, and thus
dephosphorylation of eIF4E, might simply impair total
protein synthesis and thereby block TNFα synthesis. To
assess this, we measured [35S]methionine incorpora-
tion in cells stimulated with anti-CD3/anti-CD28 plus
increasing amounts of CGP57380. Although at 40 M,
CGP57380 completely blocked eIF4E phosphorylation
and inhibited TNFα production up to 75%, total protein
synthesis was only slightly inhibited (by <20%; Figure
2D). RNAse Protection Assay (RPA) analysis was per-
formed to assess whether CGP57380 affected the
levels of the TNFα mRNA. The data (Figures 2E and 2F)
suggest there may be a modest decrease (25%, when
normalized to the GAPDH control) but that this is much
smaller than the marked effect on overall TNFα produc-
tion (75% inhibition). Thus, although Mnk inhibition may
conceivably affect both the stability and translation of
the TNFα mRNA, it seems that the Mnks regulate TNFα
production mainly by modulating its translational effi-
ciency. Therefore, it was possible that Mnk1 and MK-2
cooperate to regulate TNFα production posttranscrip-
tionally. Consistent with this, the partial effect of SB203580
(which would block MK-2 activation) was substantially
increased by cotreatment with CGP57380 (data not
shown).
Although CGP57380 clearly does not impair the sig-
naling pathways that lead to activation of Erk or p38
MAP kinase/MK-2, we wanted to rule out the possibilitythat it might exert its effects by interfering with other
signaling events. We therefore tested a closely related
compound (SHN-093) in which a single hydrogen is re-
placed by a methyl group (Figure 3A). As shown in Fig-
ures 3B and 3C, SHN-093 does not inhibit Mnk activity
in vitro or within cells. It also fails to block TNFα pro-
duction by Jurkat cells (Figure 3D). Because it seems
most unlikely that the single substitution would result
in loss of activity both against the Mnks and against
any hypothetical second relevant target, these data re-
inforce the evidence that the inhibition of TNFα produc-
tion by CGP57380 reflects blockade of Mnk function.
SHN-093 may be a useful negative control for CGP57380.
Because CGP57380 inhibits Mnk1 and Mnk2, we
cannot distinguish from the data in Figure 2 which is
involved in regulating TNFα production. However, while
Mnk2 has high basal activity that is quite resistant to
upstream signaling blockade (Scheper et al., 2001),
Mnk1 has low basal activity that is stimulated via either
the Erk or p38 MAP kinase signaling pathways that are
activated upon T cell stimulation (Wang et al., 1998).
Mnk1 is thus a better candidate than Mnk2 for mediat-
ing the effects of activation of these pathways on TNFα
expression. To explore further the possible role of Mnk1
in TNFα biosynthesis, we exploited small inhibitory
RNA-mediated interference (siRNA) to decrease Mnk1
levels in Jurkat T cells and assessed its effect on TNFα
output. O’Loghlen et al. (2004) have previously shown
that in HEK293T cells, siRNA is effective in decreasing
Mnk1 levels and impairing eIF4E phosphorylation. Here,
we used the same siRNAs. Cells were either “mock”
transfected, transfected with a negative control pair of
oligonucleotides (siRNA-NS), or with a pair designed to
target Mnk1 (siRNA-M3). At intervals of 24, 48, 72, or
96 hr after transfection, cells were either lysed and ana-
lysed for Mnk1 or actin (loading control) by Western
blot (Figure 3E, lower part) or challenged with anti-CD3/
anti-CD28 for 2.5 hr, after which TNFα production was
assessed by ELISA (Figure 3E, upper part). Treatment
of cells with siRNA-M3 reduced Mnk1 levels signifi-
cantly at all times tested, although the effect was par-
tial. Using the same oligonucleotides, O’Loghlen et al.
(2004) achieved greater reduction of Mnk1 expression:
possible reasons for the partial effect seen here include
lower transfection levels with the Jurkat cells and, per-
haps, lower efficiency of siRNA in these cells (this var-
ies greatly between cell types). No change in Mnk1
levels was seen in mock-transfected cells or in ones
that received siRNA-NS (Figure 3E). Strikingly, TNFα
production was markedly and reproducibly impaired in
the Mnk1-siRNA treated cells, relative to the two sets
of controls, confirming further a role for Mnk1 in TNFα
production. The partial inhibition of TNFα synthesis
likely reflects the partial nature of Mnk1 knockdown,
but could also be due to roles for Mnk2.
Expression of Mnk1 Enhances Translation
of a Reporter mRNA Containing the TNF 3UTR
It is hard to explain the effect of Mnk1 on translation of
a specific mRNA through its ability to phosphorylate
the known substrate, eIF4E, as it binds all cytoplasmic
mRNAs. We therefore wondered whether the Mnks
might exert an effect via the regulatory region of TNFα
Immunity
180Figure 2. Mnk Inhibition Blocks the In Vivo
Production of TNFα
Jurkat cells growing in DMEM 10% FCS
were pretreated for 1 hr with increasing con-
centrations of CGP57380 or DMSO (vehicle)
and then stimulated with anti-CD3 plus anti-
CD28 before harvesting.
(A) eIF4E phosphorylation was analyzed by
isoelectric focusing (IEF) and immunoblot-
ting with anti-eIF4E 30 min after stimulation.
Positions of phospho- and dephospho-
eIF4E are shown. One representative experi-
ment from a total of three is shown.
(B) TNFα secretion was determined by ELISA
in cell supernatants 90 min after stimulation.
The data represent the average ± SD of three
independent experiments.
(C) Phosphorylation states of Erk1/2 and
hsp27 were examined by immunoblotting
with phosphospecific antibodies 30 min after
stimulation. Anti-Erk2 was used for loading
controls.
(D) 30 min after stimulation, 35S-methionine
was added and the cells were incubated for
a further 90 min. Cells were then extracted
and samples processed to measure incorpo-
ration of label into trichloroacetic acid-pre-
cipitable material. Incorporation was normal-
ized to the protein content of each sample.
The mean ± SD of two independent experi-
ments assayed in triplicate is shown.
(E) Endogenous mRNA levels for TNFα and
GAPDH were measured by RPA. Only the
parts of the urea-denaturing gel containing
the protected TNFα and GAPDH probes are
shown. A representative experiment from
three performed is shown.
(F) Radioactivity in protected bands in (E)
was quantified by phosphorimager analysis.
The ratio between the signals for the bands
corresponding to TNFα and GAPDH mRNAs
was calculated. The data represent the
average ± SD of three independent experi-
ments.mRNA, which lies within the 3#UTR. To eliminate the
effects of T cell activation on transcription and splicing,
it was preferable to use a transiently transfected repor-
ter vector containing the regulatory elements of the
TNFα mRNA (or appropriate negative controls) rather
than looking at the endogenous mRNA.
To validate the use of GFP reporter constructs to
study the role of the TNFα 3#UTR in its posttranscrip-
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lional regulation, we checked expression levels of both
eporter constructs and their ability to respond to T cell
ctivation. GFP expression was 15-fold higher in cells
ransfected with a vector encoding GFP fused to the
lobin 3#UTR (glob-GFP-glob) than in cells that re-
eived the vector for GFP fused to the TNFα 3#UTR
glob-GFP-tnf) (Figures S1A–S1C); at the transcript
evel, the former construct gave 2.5-fold higher mRNA
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181Figure 3. SHN-093 Does Not Inhibit the Mnks
or TNFα Production
(A) Structures of CGP57380 and SHN093.
(B) The activity of recombinant Mnk1 was
tested in an in vitro kinase assay using recom-
binant eIF4E in the presence of CGP57380 or
SHN-093. The part of the autoradiogram show-
ing labeled eIF4E is shown.
(C) Jurkat cells growing in DMEM plus 10%
FCS were pretreated for 1 hr with increasing
concentrations of CGP57380 or SHN-093
and then stimulated with anti-CD3 plus anti-
CD28 for 30min. Cell lysates were prepared,
and the state of eIF4E phosphorylation was
determined.
(D) TNFα secretion was analysed by ELISA
in cell supernatants 90 min after stimulation.
The data represent the average ± SD of three
independent experiments.
(E) Jurkat cells were transfected with the
indicated siRNAs as described in Supple-
mentary Material. At 24, 48, 72, and 96 hr
after transfection, cells were stimulated with
anti-CD3/anti-CD28 for 2.5 hr and the levels
of TNFα secretion determined by ELISA (±
SD, n = 3). The data represent the average
± SD of three independent experiments. The
same cells were analyzed for Mnk1 levels by
immunoblotting (upper panels). As loading
control, membranes were probed with anti-
actin (lower panels).expression (Figures S1D and S1E). These data thus in-
dicate that the 3#UTR of the TNFα message negatively
modulates mRNA stability and translation in T cells. We
next tested the effect of T cell activation on expression
of the constructs. While glob-GFP-tnf responded to
TCR and CD28 engagement, the control construct did
not. GFP expression from the glob-GFP-glob mRNA
was almost unchanged after stimulation, while the level
of GFP derived from the glob-GFP-tnf mRNA rose
quickly and markedly after treatment with anti-CD3/
anti-CD28, showing a 12-fold increase at the level of
protein (Figure S2A) and a 4-fold increase in transcript
levels (Figures S2B and S2C). Because both reporters
are driven by the same promoter and lack introns, the
differences cannot be due to changes in transcription
or splicing and likely reflect modulation of transcript
stability and/or translation after T cell activation. Be-
cause endogenous TNFα induction is regulated throughsignaling events that require both the Erk and the p38
MAP kinase pathways, we tested whether these signal-
ing events regulated the reporter containing the 3#UTR
of the TNFα mRNA. We observed that, in combination,
PD98059 and SB203580 almost completely blocked the
enhanced expression of GFP from the glob-GFP-tnf re-
porter at both protein (Figure S3A) and transcript levels
(Figures S3B and S3C). It therefore appears that, in T
cells, these pathways regulate both the translation of
the glob-GFP-tnf reporter mRNA and its level of expres-
sion (presumably via changes in mRNA stability). These
effects could be exerted through a common target of
the Erk and p38 MAP kinase pathways such as Mnk1.
To study further the role of Mnk1 in regulating TNFα
synthesis, we cotransfected Jurkat cells with our repor-
ter constructs and a vector encoding wild-type (WT)
Mnk1 or the corresponding empty vector. We also used
the T2A2 mutant of Mnk1, in which Thr197 and 202 in
Immunity
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GFP from the glob-GFP-tnf mRNA
Jurkat cells were transfected with 10 g of
glob-GFP-tnf and 20 g of Mnk1 constructs
coding wild-type Mnk1 (Mnk1 WT), a low ac-
tivity form (Mnk1 T2A2) or with empty vector
(Vector). 24 hr after transfection, cells were
harvested to analyze eIF4E phosphorylation
and GFP expression.
(A) Upper section: levels of phosphorylation
of endogenous eIF4E in transfected cells
were determined as described in Figure 2.
Levels of GFP in transfected cells was deter-
mined by immunoblotting of total cell lysates
with anti-GFP. To assess the loading, the
Western blot was reprobed with anti-actin.
Lower section: HEK293 cells were trans-
fected with the same plasmids and phos-
phorylation of endogenous eIF4E was deter-
mined as for the Jurkat cells.
(B) GFP fluorescence of transfected cells.
GFP expression is calculated as the median
fluorescence intensity of the cell population.
The data represent the average ± SD of five
independent experiments, each performed
in duplicate.
(C) Total RNA was extracted from aliquots of
the same cells to analyze specifically the
levels of GFP and GAPDH mRNAs by RNase
protection. The amount of radioactivity in
protected bands was determined by phos-
phorimager analysis and is shown as GFP/
GAPDH ratio. The average ± SD of three in-
dependent transfections is presented.
(D) Translational efficiency (GFP protein)/
(GFP mRNA) was calculated for samples
represented in (B) and (C). The figure shows
the mean ± SD of the ratio [(GFP protein)/
(GFP mRNA)] from three independent experi-
ments shown in (B) and (C).
(E) Jurkat cells were transfected with 10 g
of glob-GFP-tnf and increasing amounts of
the Mnk1 constructs or empty vector. 24 hr
after transfection, cells were harvested to
analyse GFP expression by FACS. The mean ±
SD of three independent transfections, each
with duplicate determinations, is shown.
(F and G) Jurkat cells were transfected with 10g of glob-GFP-tnfARE (F) or glob-GFP-glob (G) and 20g of wild-type Mnk1 (Mnk1 WT) or
empty vector (Vector). 24 hr after transfection, GFP expression in live cells was determined by FACS analysis. The mean ± SD of three
independent transfections is shown. The asterisk represents data significantly differing from “vector” values (p < 0.01, Student’s t test).the T-loop have been mutated to alanines. This mutant
does not undergo autophosphorylation and has much
lower activity against eIF4E than WT Mnk1 (Waskiewicz
et al., 1999). As expected, transfection of cells with WT
Mnk1 resulted in a marked increase in eIF4E phos-
phorylation (Figure 4A, top section), demonstrating that
the overexpressed Mnk1 is active in these cells. The
T2A2 mutant caused only a small increase in eIF4E
phosphorylation either in Jurkat or in HEK293 cells (Fig-
ure 4A, lower panel). Thus, although it has previously
been described as inactive (Waskiewicz et al., 1997),
this T loop mutant actually shows low residual activity.
Expression of WT Mnk1 markedly increased the ex-
pression of GFP encoded by glob-GFP-tnf, whereas the
T2A2 mutant had no obvious effect (Figure 4A). We also
quantified GFP expression by FACS analysis of the
cells (Figure 4B). Again, it is clear that WT Mnk1 strongly
increases GFP expression, whereas Mnk1[T2A2] exerted
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uonly a slight stimulatory effect. Thus, Mnk1 can increasehe expression of a protein encoded by an mRNA con-
aining the TNFα 3#UTR.
In principle, Mnk1 could enhance GFP expression
rom the glob-GFP-tnf reporter either by enhancing the
tability of the mRNA or its translation. In fact, expres-
ion of WT Mnk1, if anything, slightly repressed the
evel of the glob-GFP-tnf reporter mRNA, although this
ffect was not statistically significant (p = 0.22, Figure
C). A modest trend towards decreased transcript
evels was also seen in cells expressing Mnk1[T2A2].
his indicated that the stimulatory effect of Mnk1 on
FP expression is not due to increased mRNA levels.
o assess its effects on the translation of the mRNA,
e calculated the translational efficiency: GFP protein
evels/transcript levels (Han et al., 1990). Expression of
T Mnk1 greatly enhanced this ratio, while expression
f Mnk1[T2A2] had a smaller stimulatory effect (Fig-
re 4D).
To study further the relationship between Mnk1 and
Posttranscriptional Targeting of TNF 3#UTR by Mnk
183GFP expression, we examined the effect of increasing
amounts of Mnk1 or Mnk1[T2A2]. As the amount of
Mnk1 DNA used in the transfection was increased, so
the level of GFP expression also rose (Figure 4E). There
may be a threshold effect here, as low levels of DNA (1
or 3 g) had no detectable effect on GFP expression
while larger amounts elicited a marked increase. Taken
together, these data provide evidence for direct in-
volvement of Mnks in the translation of a specific
mRNA, i.e., one containing the TNFα 3#UTR.
To test whether the Mnks were targeting the AU-rich
element within the TNFα 3#UTR, we used a reporter
construct containing the 3#UTR of TNFα from which the
ARE was deleted (glob-GFP-tnfARE). As expected,
since the ARE is important for destabilizing and transla-
tionally repressing the mRNA, the basal level of GFP
expression from the ARE construct was much higher
than for the one containing WT TNFα 3#UTR (compare
Figures 4F and 4B). Although transfection with Mnk1
did increase the expression of GFP from this construct,
the effect was only half that seen with the full-length
3#UTR, showing that the ARE is required for the full ef-
fect of the Mnks. The fact that Mnk1 still enhanced GFP
expression from the ARE construct likely indicates
that other features of the 3#UTR are also involved in its
regulation, e.g. hnRNP A1 could also be binding out-
side the ARE. To test this, we analysed the complexes
formed between hnRNP A1 and TNF mRNA by UV
crosslinking (data not shown). The experiment showed
that hnRNP A1 protects two fragments of the TNFα
mRNA from digestion with RNase T1, which might rep-
resent the ARE and an additional region. This suggests
that focusing on the ARE might overlook other regions
in the 3#UTR or elsewhere in the mRNA that are also
important in the regulation of translation of the TNFα
mRNA. After all, while the minimal AU-rich sequence
necessary to confer instability has been identified, the
features determining the translational rate of an mRNA
have not yet been fully characterized.
To test further the specificity of this effect, we used
the glob-GFP-glob reporter since this 3#UTR lacks any
relevant regulatory elements. Although transfection
with Mnk1 did slightly increase expression of GFP from
this construct, the effect barely reached significance
(Figure 4G) and was much smaller than the four-fold
increase seen for GFP expression from the glob-GFP-
tnf reporter (p < 0.01). This small increase might just
reflect a role for the Mnks in general protein synthesis.
Because inhibition of the Mnks slightly decreases total
protein synthesis (Figure 2D), one would expect their
overexpression to increase general mRNA translation,
including the glob-GFP-glob construct.
Given this, and the data in Figure 2D, it is hard to
explain the effect of Mnk1 on the translation of mRNAs
containing the TNFα 3#UTR through changes in the
phosphorylation of eIF4E, which binds all cytoplasmic
mRNAs. The effects of Mnk1 expression or inhibition
are more likely to reflect its action on specific target
proteins, e.g., ones that bind specifically the 3#UTR of
the TNFα mRNA. We therefore tested whether the Mnks
could phosphorylate ARE binding proteins (ARE-BPs),
substrates that associate specifically with such mRNAs
and may regulate their translation (Figure 5A).Mnks Phosphorylate Proteins that Bind
to the 3UTR of the TNF mRNA
To do this, we used a biotinylated oligoribonucleotide
consisting of the ARE of TNFα to pull down ARE-BPs
from Jurkat cell lysates. We then tested whether they
could be phosphorylated by the Mnks. The same sev-
eral polypeptides became phosphorylated in this assay
using either Mnk1 (data not shown) or Mnk2 (Figure 5B).
No labeling was observed when the bound proteins
were incubated with p38 MAP kinase plus SB203580 at
the concentration used to block any “spurious phos-
phorylation” due to this enzyme, which is used to acti-
vate the Mnks. Thus, these proteins are phosphorylated
by the Mnks, not by any residual contaminating p38
MAP kinase. Moreover, in separate experiments (not
shown), we confirmed that hnRNP A1 is not a substrate
for p38 MAP kinase.
The labeled polypeptides were then identified by
(tryptic) peptide mass fingerprinting. All three are hnRNP
proteins, i.e., hnRNPs A0, A1 and JKT BP. The first two
are already known to bind to AREs (Rousseau et al.,
2002; Hamilton et al., 1997). To further confirm the bind-
ing specificity of these hnRNPs, we tested by Western
blotting for the presence of hnRNP A1 and hnRNPA0 in
a pull down with an oligo RNA encoding either for the
TNFα ARE or an irrelevant RNA (Figure 5C). Both
hnRNPs were found to bind only to the ARE-containing
oligo RNA. Because hnRNP A0 is known to be phos-
phorylated by MK-2 (Rousseau et al., 2002), we de-
cided to focus on hnRNP A1, which plays important
roles in RNA metabolism (Hamilton et al., 1997). To con-
firm that hnRNP A1 is indeed an Mnk1 substrate we
expressed it in E. coli and incubated it with Mnk1 (Fig-
ure 5D). Mnk1 clearly phosphorylates recombinant
hnRNP A1 in vitro, although slightly less efficiently than
eIF4E, a positive control.
Identification of the Sites within hnRNP A1
Phosphorylated by Mnk1
To further characterize hnRNP A1 as a substrate for the
Mnks, it was important to identify the sites phosphory-
lated by the Mnks, as a necessary step to determining
whether hnRNP A1 is phosphorylated in vivo at these
residues by the Mnks.
Recombinant hnRNP A1 made in E. coli was phos-
phorylated by Mnk1 in vitro, and then digested with
trypsin. The tryptic peptides were separated by chro-
matography by reverse-phase HPLC on a C18 column.
Two major 32P-labeled species were observed, that
eluted close together on the HPLC (Figure 5E) and also
migrated similarly on the two-dimensional map (Figure
5F). The masses of the peptides (m/z = 1774.67 and
m/z = 1277.48) corresponded to that of monophosphor-
ylated forms of the tryptic peptides comprising residues
184-194 (QEMASASSSQR) and 301-318 (NQGGYGGSS
SSSSYGSGR). This was confirmed by Edman sequenc-
ing, which identified Ser192 as the site of phosphoryla-
tion in one peptide (“b” in Figure 5F and Figure 6), and
Ser310, Ser311 and Ser312 in the second peptide (pep-
tide “a”). The ms/ms spectrum for the second peptide
did not contain any species where Ser313 was phos-
phorylated, and thus the 32P at this position in the cycle
burst is due to trailing from Ser312. The mass spectrome-
try showed that the peptide containing Ser310/1/2 was a
Immunity
184Figure 5. Mnks Phosphorylate Proteins that Bind to the 3#UTR of the TNFα mRNA In Vitro
(A) Schematic diagram of recruitment of Mnks to the eIF4F complex bound to the 5# cap of an mRNA. Mnks bind the C terminus of eIF4G, a
scaffold protein that also binds eIF4E and PABP thereby potentially circularizing the mRNA. Arrows indicate phosphorylation of eIF4E by the
Mnks and putative in vivo phosphorylation of proteins bound to the ARE of the TNFα mRNA.
(B) ARE-BPs immunoprecipitated with an oligoribonucleotide corresponding to the ARE of the TNFα mRNA were incubated in the presence/
absence of activated Mnk2 and [γ-32P]ATP. Proteins were separated by SDS-PAGE and analyzed by autoradiography. Labeled bands were
identified by tryptic mass fingerprint. As negative control, the p38 MAPK used to activate Mnk2 was tested in the presence of SB203580 (this
compound is always present in the Mnk assays to inhibit any residual p38 MAPK).
(C) Western blot for hnRNP A0 or hnRNP A1 from pull-downs performed with either an irrelevant oligo or one containing the TNFα ARE.
(D) An in vitro kinase assay was performed with Mnk1 in the presence of hnRNP A1 or eIF4E. As a control, the p38MAPK was also used in
the presence of SB203580. Arrowheads indicate bands derived from the recombinant Mnk1 used.
(E) Purified hnRNP A1 was phosphorylated in vitro by activated Mnk1 and subjected to SDS-PAGE. The band corresponding to hnRNP A1
was excised, digested with trypsin and the resulting peptides were separated by reverse-phase chromatography on a C18 column equilibrated
in 0.1% trifluoroacetic acid and developed with acetonitrile. 32P-radioactivity is shown by the solid line and the acetonitrile gradient by the
broken line. The masses of the two major tryptic phosphopeptides were obtained by MALDI-TOF. The sequence of the peptides and the sites
of phosphorylation were identified by solid-phase sequencing.
(F) Two-dimensional tryptic phosphopeptide map of hnRNP A1 phosphorylated in vitro by Mnk1. The positions of the origin and the peptides
“a” and “b” containing the identified phosphorylation sites are indicated. The direction of chromatography (vertical arrow) and polarity of
electrophoresis (+/−) are shown.
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185Figure 6. Analysis of Phosphorylation of Re-
combinant and Endogenous hnRNP A1
(A–D) Two dimensional analysis of tryptic
peptides from bacterially expressed hnRNP
A1 wild-type (A), hnRNP A1 S192A (B),
hnRNP A1 S311A (C) and hnRNP A1 S310A
S311A S312A (D), phosphorylated in vitro by
Mnk1. The peptides “a” and “b” containing the
Mnk phosphorylation sites identified in vitro
are indicated.
(E–H) Endogenous hnRNP A1 was immuno-
precipitated from metabolically labeled Jur-
kat cells, digested with trypsin, and the pep-
tides were resolved on two-dimensional
maps. Maps correspond to hnRNP A1 from
unstimulated Jurkat cells (E), cells incubated
with CGP57380 for 45 min (CGP57380, F),
stimulated with anti-CD3/anti-CD28 for 30
min (anti-CD3/anti-CD28, G), or pretreated
with CGP57380 prior to stimulation (anti-
CD3/anti-CD28+CGP57380, H). Peptides “a”
and “b” containing the Mnk phosphorylation
sites identified in vitro are indicated by la-
beled arrows.mixture of monophosphorylated peptides and did not
contain any bis- or tris-phosphorylated forms, suggest-
ing that, although Mnk can phosphorylate more than
one residue in this peptide, it phosphorylates only one
at a time. hnRNP A1 mutants in which all four serines
were changed to alanines could not be phosphorylated
in vitro by Mnk1 and allowed us to determine which
spot in the 2D map corresponded to which of the phos-
phopeptides “a” and “b” (Figures 6A–6D).
The sequences flanking the phosphorylation sites
identified in hnRNP A1 do not resemble those around
the Mnk-site in eIF4E (Ser209). Because the Mnks can
only phosphorylate eIF4E when it is properly folded and
not when it is denatured, we believe that the Mnks rec-
ognize a higher order structure not primary sequence.
Phosphorylation of hnRNP A1 In Vivo
at Mnk1 Sites
To determine whether hnRNP A1 is phosphorylated
in vivo at the sites identified in vitro as targets for Mnk1,
Jurkat cells were metabolically labeled with 32P-ortho-
phosphate, and hnRNP A1 was immunoprecipitated
from the cell lysates. The antibody used to immuno-
precipitate hnRNP A1 binds to the protein whether or
not it is associated with hnRNP complexes. In vivophosphorylation of hnRNP A1 was examined in stim-
ulated cells in the presence or absence of the Mnk
inhibitor. After tryptic digestion of the immunoprecipi-
tated hnRNP A1, peptides were separated on two-
dimensional maps. In unstimulated cells, hnRNP A1 is
already phosphorylated at several residues as indi-
cated by the different radiolabeled peptides obtained
(Figure 6E). The basal phosphorylation of hnRNP A1
might actually be due to the stress derived from the
incubation of these cells with phosphate-free medium,
which they did not tolerate well. In unstimulated cells,
two faint spots matched the peptides phosphorylated
in vitro (Figure 6E), and these were completely elimi-
nated by the addition of the Mnk inhibitor (Figure 6F).
Moreover, T cell stimulation increased phosphorylation
of these peptides (Figure 6G), and this was also pre-
vented by pretreatment of cells with CGP57380 (Fig-
ure 6H).
This experiment shows that hnRNP A1 is phosphory-
lated in vivo upon T cell stimulation at residues 192 and
310/1/2 and that this phosphorylation is sensitive to the
Mnk inhibitor. Thus, hnRNP A1 appears to be an in vivo
Mnk substrate. Altogether, the data argue in favor of an
in vivo role for the Mnks in regulating cytokine produc-
tion through phosphorylation of ARE binding proteins
such as hnRNP A1. The next step was to examine
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186Figure 7. hnRNP A1 Binding to TNFα mRNA
(A and B) Binding of bacterially expressed
hnRNP A1 to the TNFα oligoribonucleotide
was analysed by surface plasmon resonance
BiaCore analysis as described in Experimen-
tal Procedures. (A) Binding profile. The oli-
goribonucleotide containing the TNFα ARE
(sample channel) or the irrelevant oligo (con-
trol channel) were attached to the sensor
chip. Association and dissociation profiles
were recorded for five different concentra-
tions (15.6, 31.25, 62.5, 125, and 250 nM) of
either phosphorylated or mock phosphory-
lated hnRNP A1 (incubated with inactive
Mnk1) (B) The response level at steady-state
binding was plotted vs. the log of the hnRNP
A1 concentration. Binding to the biotinylated
irrelevant oligoribonucleotide was used as a
measurement of nonspecific binding and
subtracted from the binding observed with
the TNFα oligoribonucleotide.
(C) Jurkat cells were either untreated or stim-
ulated with anti-CD3/anti-CD28 in the ab-
sence or presence of CGP57380. After 1 hr
of stimulation cells were harvested and RNA
extracted from either total cell lysates or
hnRNP A1 IPs (see Supplemental Experi-
mental Procedures for details). From the
RNA obtained, RT-PCR reactions were per-
formed for TNFα and GAPDH. Levels of the
PCR products from the TNFα and GAPDH
mRNAs present in the hnRNP A1 IPs (upper
panels) or in total RNA extracts (lower pan-
els) are shown.
(D) Extracts from Jurkat cells treated as in C,
were fractionated to give cytoplasmic (C)
and nuclear (N) fractions as described in
Supplemental Data. Aliquots representing
7% of each fraction were analyzed by West-
ern blotting with antibodies directed against
hnRNP A1, lamin B and α-tubulin.
(E) Possible model for the regulation of
hnRNP A1 by Mnk-mediated phosphoryla-
tion. For details, see main text.whether Mnk-mediated phosphorylation affected hnRNP
A1 function.
Phosphorylation of hnRNP A1 by the Mnks Reduces
Its Binding to the 3UTR
Our hypothesis is that the Mnks regulate specific mes-
sages via phosphorylation of ARE-BPs. This phosphor-
ylation may disrupt the protein complexes bound to the
3#UTR responsible for the translational repression of
the message. To test whether Mnk-mediated phosphor-
ylation of hnRNP A1 modulated its binding to the RNA,
we performed surface plasmon resonance (SPR) bind-
ing studies, as described in the Supplemental Experi-
mental Procedures. As shown in Figures 7A and 7B, bac-
terially expressed hnRNP A1 phosphorylated in vitro with
active Mnk1 bound with lower affinity to the immobilized
TNFα oligoribonucleotide. This suggests that phosphor-
ylation negatively regulates binding of hnRNP A1 to the
ARE of the TNFα mRNA.
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he TNFα mRNA by gel mobility shift analysis. RNAase
igestion to remove unbound RNA was required to
tudy the binding of purified hnRNP A1 and UV cross-
inking was needed prior to digestion. Unfortunately,
he crosslinking between TNFα and hnRNP A1 was in-
fficient, rendering this approach unsuitable for in vitro
ssessment of the affinity of hnRNP A1 for the TNFα
RNA (data not shown).
We considered it important to examine the interac-
ion between hnRNP A1 and the TNFα mRNA in vivo.
o do this, we performed ribonucleoprotein (RNP) im-
unoprecipitation (IP) assays (Niranjanakumari et al.,
002). Jurkat cells stimulated in the presence or ab-
ence of CGP57380, were fixed in vivo with formalde-
yde and the crosslinked RNP complexes were then
mmunoprecipitated with an anti-hnRNP A1 antibody.
o allow further characterization of the immunoprecipi-
ated components, the crosslinks were reversed. The
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187RNA was then extracted from the samples and ana-
lyzed by RT-PCR. No products were amplified from the
sample obtained with anti-hnRNP A1 using primers for
GAPDH (negative control, Figure 7C upper panel; data
in lower panel confirm the efficacy of the primers), indi-
cating the specificity of the IP. In contrast, the TNFα
mRNA clearly coimmunoprecipitated with hnRNP A1 in
stimulated T cells, indicating that this protein:RNA in-
teraction occurs in cells. Strikingly, the level of binding
was much greater when cells were pretreated with
CGP57380 prior to TCR stimulation. The fact that we
saw obvious alterations in the amount of TNFα mRNA
that was amplified shows that the PCR reaction is oc-
curring within a range where differences are clearly de-
tected. Thus, Mnk inhibition enhances the association
of the TNFα mRNA with hnRNP A1, in agreement with
the SPR data where phosphorylation of hnRNP A1 de-
creased its affinity for the TNFα ARE. Total TNFα mRNA
and GAPDH were also analysed by RT-PCR on total
RNA extracted from whole-cell lysates (Figure 7C,
lower panels). While TNFα mRNA is undetectable in un-
stimulated cells, it is greatly induced upon activation
of T cells. The levels reached upon stimulation are not
affected by the Mnk inhibitor, further confirming that
the Mnks may regulate the translational efficiency of
the TNFα mRNA rather than its transcription, process-
ing or stability. GAPDH levels were constant in all con-
ditions tested.
We therefore conclude that phosphorylation of
hnRNP A1 by the Mnks decreases its binding to the
TNFα 3#UTR both in vitro and in vivo. Consistent with
a translation repressor role for hnRNP A1, it has re-
cently been found to act cooperatively with CUGBP2
during translational blockade of the COX-2 mRNA
(Mukhopadhyay et al., 2003). The COX-2 mRNA con-
tains an ARE very similar to that of TNFα, likely explain-
ing why hnRNP A1 binds both mRNAs.
Moreover, our results agree with the proposed model
for the nucleo-cytoplasmic shuttling of hnRNP A1.
hnRNP A1 is believed to exit the nucleus bound to
mRNA and to re-enter in a complex with other proteins
(Weighardt et al., 1995). However, although the Mnks
might be involved in the recycling of hnRNP A1, they do
not affect the overall cellular distribution of the protein.
Neither treatment of cells with the Mnk inhibitor nor
their stimulation with anti-CD3/anti-CD28 affected the
nucleocytoplasmic distribution of hnRNP, which was
primarily nuclear, although a substantial proportion was
also recovered in the cytoplasm (Figure 7D).
We have shown that in the cytoplasm, phosphoryla-
tion by the Mnks decreases the affinity of hnRNP A1 for
the mRNA, leading to its release. We suggest that this
contributes to the derepression of the translation of the
TNFα mRNA (Figure 7E), although the exact mecha-
nisms by which hnRNP A1, and other ARE binding pro-
teins, controls translation remain to be elucidated.
Conclusions
The present data provide several lines of evidence that
the Mnks play a key role in the regulation of the synthe-
sis of the inflammatory cytokine TNFα and suggest that
this involves phosphorylation by the Mnks of proteins(e.g. hnRNP A1) that bind the regulatory AREs of the
3#UTR of its mRNA. However, formal proof that the ef-
fects of the Mnks on TNFα expression are mediated
through phosphorylation of hnRNP A1 is still lacking.
The Mnks thus phosphorylate proteins that bind either
to the 5#- or 3#UTRs of eukaryotic mRNAs and this is
likely facilitated by the Mnks association with the eIF4F
complex which interacts with both ends of the mRNA.
Since Mnk1 is activated by Erk and p38 MAP kinases,
it may account for the link between Erk signaling and
the posttranscriptional regulation of cytokine expression.
In summary, this study identifies the Mnks as poten-
tially important novel players in the control of TNFα pro-
duction. Our initial data (unpublished) suggest they
may be also involved in the regulation of other cyto-
kines. The Mnks are consequently promising novel tar-
gets for specific anti-inflammatory therapy. It will be im-
portant to establish whether cytokine production is
compromised, for example, in the mice lacking Mnk1
and Mnk2 that were recently described (Ueda et al.,
2004). Although the lack of phenotype reported by
these workers may at first appear surprising given our
data showing a role for the Mnks in TNFα synthesis, it
should be noted that no phenotype was initially seen
for the MK-2 knock-out mice under sterile controlled
laboratory conditions (Kotlyarov et al., 1999) even
though it is now well established that this enzyme does
play an important role in regulating cytokine biosyn-
thesis.
Supplemental Data
Supplemental Data include Experimental Procedures, four addi-
tional figures, a table, and Supplemental References and can be
found with this article online at http://www.immunity.com/cgi/
content/full/23/2/177/DC1/.
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